Skip to main content

Soleus Capital Management, L.P.

Position in SNDX — Syndax Pharmaceuticals Inc

CIK 1802630 GREENWICH, CT

Position in SNDX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$35,588,932
-$4,751,638 QoQ
Shares Held
1,628,039
-5.7% QoQ
Ownership
1.82%
of shares outstanding
% of Portfolio
1.23%
of 13F equity value
Holder Rank
#19
of 242 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SNDX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Soleus Capital Management, L.P. holds $1,743,217,207 across 63 Biotechnology names. SNDX ranks #11 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SNDX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $35,588,932 1,628,039
2026-03-31 $40,340,570 1,726,908
2025-12-31 $47,211,781 2,247,110
2025-09-30 $30,956,312 2,012,110
2025-06-30 $10,227,610 1,092,110
2025-03-31 $10,032,053 816,610
2024-12-31 $32,944,240 2,492,000
2024-09-30 $21,001,442 1,090,984
2024-06-30 $16,968,045 826,500
2024-03-31 $8,782,200 369,000
2023-12-31 $11,107,540 514,000
2023-09-30 $1,735,140 119,500
2023-06-30 $4,449,718 212,600
2023-03-31 $6,813,312 322,600
2022-12-31 $5,599,000 220,000
2020-03-31 $230,150 20,980